- Wednesday, 11 November
- 09:00 - 9:45
- Plenary 1 - AMR in War, Conflict and Displacement
- Sabiha Essack
- South Africa
Sabiha Essack
South Africa
Sabiha Essack is the South African Research Chair in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal. She is the co-lead of the Multi-Stakeholder Partnership Platform Action Group on “Stewardship across the Lifecycle of Antimicrobials: a One Health Approach” and member of the WHO Strategic and Technical Advisory Group for AMR (STAG-AMR). Sabiha serves as the Senior Implementation Research Advisor to the International Centre for AMR Solutions (ICARS) based in Denmark and chairs the Global Respiratory Infection Partnership (GRIP). She is a member of the World Economic Forum Global Futures Council for AMR, member of the International Pharmacy Federation (FIP) AMR Commission, member of the Wellcome Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC) and she serves on the Advisory Board of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and the Fleming Fund Expert Advisory Group. Her research focuses on the molecular epidemiology of AMR using next generation sequencing and bioinformatics as well as One Health systems strengthening in the context of AMR. ORCID: https://orcid.org/0000-0003-3357-2761 Google Scholar: https://scholar.google.com/citations?user=eejmC2kAAAAJ&hl=en
- 15:30 - 16:15
- Plenary 2 - Platform Trials as a way forward for ID Research
- Asha Bowen
- Australia
Asha Bowen
Australia
Professor Asha Bowen is a paediatric infectious diseases clinician-researcher focused on reducing the burden of infectious diseases in Australia’s Aboriginal children. For more than 15 years, she has led a program of translational research spanning remote community-based clinical trials, laboratory science, and bedside care.
Her work has delivered major advances in skin infection control and the prevention of downstream complications, including rheumatic heart disease. She led the See, Treat, Prevent Skin Sores and Scabies (SToP) Trial, which halved impetigo prevalence among children in the Kimberley through improved identification and treatment training, evidence-based care using a ‘treatment as prevention’ framework, and environmental health and health promotion activities. This work has expanded to children living in urban settings through the Koolungar (Children) Moorditj (Strong) Healthy Skin Project. These programs reflect a long-term, community-led approach to improving child health and informed the development of the National Healthy Skin Guidelines.
Professor Bowen also leads the paediatric arm of the Staphylococcus aureus Network Adaptive Platform (SNAP) Trial, a global pragmatic trial aimed at improving bacteraemia outcomes.
She is internationally recognised for her leadership in paediatric infectious diseases and skin health and is the immediate Past President of the World Society for Paediatric Infectious Diseases.
- Thursday, 12 November
- 09:00 - 9:45
- Plenary 3 - The next pandemic; are we ready?
- Daniel B. Jernigan
- USA
Daniel B. Jernigan
USA
Daniel Jernigan, MD, MPH, is an internationally recognized public health leader with more than 30 years at the CDC, where he directed the National Center for Emerging and Zoonotic Infectious Diseases and the Influenza Division. He has led responses to major health crises including anthrax, SARS, H1N1, Ebola, MERS, and COVID-19, and has authored over 160 scientific publications. Dr. Jernigan is a recipient of the Service to America Medal and has completed residencies in Internal Medicine and Preventive Medicine. He retired as a Captain from the U.S. Public Health Service, continued working at CDC in the civil service, and retired in 2025. He currently is a contributing scholar at Johns Hopkins Bloomberg School of Public Health.
- 15:30 - 16:15
- Plenary 4 - WHO Global Research Priorities for STIs
- Allisyn Carol Moran
- Switzerland
Allisyn Carol Moran
Switzerland
Coming soon
- Friday, 13 November
- 09:00 - 9:45
- Plenary 5 - Rapid diagnostics platforms
- Tristan W. Clark
- UK
Tristan W. Clark
UK
Tristan Clark is a Professor of Infectious Diseases at the University of Southampton and an Honorary Consultant at University Hospitals Southampton NHS trust. His research involves the assessment of accuracy, usability, and clinical impact of novel rapid diagnostic tests for infections. He has been awarded grant funding from NIHR, Research Councils, EU, and Industry and is the current holder of an NIHR Research Professorship. He has published the results of his trials in The New England Journal of Medicine and Lancet series journals and has introduced new point-of-care tests into clinical pathways locally and nationally. He is an editor for the Journal of Infection, a panel member the NIHR Doctoral Fellowship scheme, a council member for the International Society for Respiratory Viruses and a member of the Scientific Affairs committee of the British Infection Association. During the COVID-19 pandemic he was as an advisor to the UK Department of Health and Social Care. The aim of his research is to improve patient care and experience through the evidence-based use of rapid diagnostic tests for infection.
- 15:30 - 16:15
- Plenary 6 - Vaccine Access in Low and Middle-Income Countries
- Colleen Daniels
- UK
TBA
Coming soon
